Mostrar el registro sencillo del ítem
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients
dc.contributor.author | Trujillo-Rodriguez, M. | |
dc.contributor.author | Muñoz-Muela, E. | |
dc.contributor.author | Serna-Gallego, A. | |
dc.contributor.author | Praena-Fernández, J.M. | |
dc.contributor.author | Pérez-Gómez, A. | |
dc.contributor.author | Gasca-Capote, C. | |
dc.contributor.author | Vitallé, J. | |
dc.contributor.author | Peraire, J. | |
dc.contributor.author | Palacios-Baena, Z.R. | |
dc.contributor.author | Cabrera Alvargonzalez, Jorge julio | |
dc.contributor.author | Ruiz-Mateos, E. | |
dc.contributor.author | Poveda López, Eva | |
dc.contributor.author | López-Cortés, L.E. | |
dc.contributor.author | Rull, A. | |
dc.contributor.author | Gutierrez-Valencia, A. | |
dc.contributor.author | López-Cortés, L.F. | |
dc.date.accessioned | 2025-08-26T08:16:42Z | |
dc.date.available | 2025-08-26T08:16:42Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Trujillo-Rodriguez M, Muñoz-Muela E, Serna-Gallego A, Praena-Fernández JM, Pérez-Gómez A, Gasca-Capote C, et al. Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients. PLoS ONE. 2022;17(7 July). | |
dc.identifier.issn | 1932-6203 | |
dc.identifier.other | https://portalcientifico.sergas.gal/documentos/62e5c25ee5f0e01a6a1cf5af | * |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/20586 | |
dc.description.abstract | Background The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its severity in a high percentage of cases. Having tools to predict which patients can be safely early discharged would help to improve this situation. Methods Patients confirmed as SARS-CoV-2 infection from four Spanish hospitals. Clinical, demographic, laboratory data and plasma samples were collected at admission. The patients were classified into mild and severe/critical groups according to 4-point ordinal categories based on oxygen therapy requirements. Logistic regression models were performed in mild patients with only clinical and routine laboratory parameters and adding plasma pro-inflammatory cytokine levels to predict both early discharge and worsening. Results 333 patients were included. At admission, 307 patients were classified as mild patients. Age, oxygen saturation, Lactate Dehydrogenase, D-dimers, neutrophil-lymphocyte ratio (NLR), and oral corticosteroids treatment were predictors of early discharge (area under curve (AUC), 0.786; sensitivity (SE) 68.5%; specificity (S), 74.5%; positive predictive value (PPV), 74.4%; and negative predictive value (NPV), 68.9%). When cytokines were included, lower interferon-?-inducible protein 10 and higher Interleukin 1 beta levels were associated with early discharge (AUC, 0.819; SE, 91.7%; S, 56.6%; PPV, 69.3%; and NPV, 86.5%). The model to predict worsening included male sex, oxygen saturation, no corticosteroids treatment, C-reactive protein and Nod-like receptor as independent factors (AUC, 0.903; SE, 97.1%; S, 68.8%; PPV, 30.4%; and NPV, 99.4%). The model was slightly improved by including the determinations of interleukine-8, Macrophage inflammatory protein-1 beta and soluble IL-2R? (CD25) (AUC, 0.952; SE, 97.1%; S, 98.1%; PPV, 82.7%; and NPV, 99.6%). Conclusions Clinical and routine laboratory data at admission strongly predict non-worsening during the first two weeks; therefore, these variables could help identify those patients who do not need a long hospitalization and improve hospital overcrowding. Determination of pro-inflammatory cytokines moderately improves these predictive capacities. | en |
dc.description.sponsorship | This work was supported by Consejeria de Salud y Familia (research Project COVID-00052020 and Research Contract RH-0037-2020 to JV); Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades (PY20/01276 to APG); Instituto de Salud Carlos III (CP19/ 00159 to AGV, CP19/00146 to AR, FI19/00304 to EMM, FI19/00083 to MCGC, a way to make Europe, and COV20/00698 to support COHVIDGS), Red Tematica de Investigacion Cooperativa en SIDA (RD16/0025/0020, RD16/0025/0006 and RD16/0025/0026), Fondos FEDER; Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas-ISCIII (CB21/13/00020) Madrid, Spain. ERM was supported by the Spanish Research Council (CSIC). AR is also supported by a grant from IISPV through the project 2019/IISPV/05 (Boosting Young Talent), by GeSIDA through the III Premio para Jo ' venes Investigadores. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. | en |
dc.language.iso | eng | |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.title | Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients | * |
dc.type | Article | en |
dc.authorsophos | Trujillo-Rodriguez, L. F. M. | |
dc.authorsophos | Muñoz-Muela, E. | |
dc.authorsophos | Serna-Gallego, A. | |
dc.authorsophos | Praena-Fernández, J. M. | |
dc.authorsophos | Pérez-Gómez, A. | |
dc.authorsophos | Gasca-Capote, C. | |
dc.authorsophos | Vitallé, J. | |
dc.authorsophos | Peraire, J. | |
dc.authorsophos | Palacios-Baena, Z. R. | |
dc.authorsophos | Cabrera, J. J. | |
dc.authorsophos | Ruiz-Mateos, E. | |
dc.authorsophos | Poveda, E. | |
dc.authorsophos | López-Cortés, L. E. | |
dc.authorsophos | Rull, A. | |
dc.authorsophos | Gutierrez-Valencia, A. | |
dc.authorsophos | López, Cortés | |
dc.identifier.doi | 10.1371/journal.pone.0269875 | |
dc.identifier.sophos | 62e5c25ee5f0e01a6a1cf5af | |
dc.issue.number | 7 July | |
dc.journal.title | PLoS ONE | * |
dc.relation.projectID | Consejeria de Salud y Familia [COVID-00052020, RH-0037-2020]; Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades [PY20/01276]; Instituto de Salud Carlos III [CP19/00159, CP19/00146, FI19/00304, FI19/00083, COV20/00698]; Red Tematica de Investigacion Cooperativa en SIDA [RD16/0025/0020, RD16/0025/0006, RD16/0025/0026]; Fondos FEDER; Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas-ISCIII Madrid, Spain [CB21/13/00020]; Spanish Research Council (CSIC); IISPV [2019/IISPV/05]; GeSIDA | |
dc.relation.publisherversion | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0269875&type=printable | es |
dc.rights.accessRights | openAccess | |
dc.subject.keyword | AS Vigo | es |
dc.subject.keyword | CHUVI | es |
dc.subject.keyword | IISGS | es |
dc.typefides | Artículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis) | es |
dc.typesophos | Artículo Original | es |
dc.volume.number | 17 |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
